Expand HALO Menu
HALO MENU

Halozyme Therapeutics (HALO)'s 30-day implied volatility (IV30) was 42.0% at the close on November 16, 2026, up from 37.9% the day before, against a 52-week range of 25.4% to 56.3%. Its 20-day historical volatility was 32.3%.

Key numbers
  • 30-day implied volatility (IV30): 42.0%
  • IV30 52-week range: 25.4% to 56.3% (median 34.3%)
  • Historical volatility: 20-day 32.3%, 1-year 32.6%
  • Implied move by the nearest expiration: ±2.7%

Data as of November 16, 2026.

HALO Implied Volatility (IV) vs Historical Volatility (HV)

Market Data Delayed 15 Minutes